Corcept Therapeutics

Filed a patent for "methods and compositions for treating huntington's disease and its sysmptoms" on Fri, February 17, 2023

Filed a patent for "sulfone method of preparing pyrimidine cyclohexyl glucocorticoid receptor modulators" on Tue, May 30, 2023

Filed a patent for "pyrylium method of preparing pyrimidine cyclohexyl glucocorticoid receptor modulators" on Tue, May 30, 2023

Filed a patent for "methods for treating adrenal gland tumors" on Thu, November 28, 2024

Filed a patent for "methods for treating adrenal gland tumors" on Mon, May 22, 2023

Filed a patent for "methods of preparing intermediates of heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators" on Fri, February 24, 2023

Filed a patent for "methods of preparing intermediates of heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators" on Thu, September 26, 2024

Filed a patent for "pharmaceutical formulations containing relacorilant, a heteroaryl-ketone fused azadecalin compound" on Thu, August 22, 2024

Filed a patent for "methods for shrinking pituitary tumors" on Thu, August 22, 2024

Filed a patent for "methods of treating antipsychotic-induced weight gain with miricorilant" on Thu, August 8, 2024

Filed a patent for "methods of treating cushing's syndrome and liver disorders, and of reducing liver toxicity of other drugs administered to a patient" on Thu, July 25, 2024

Filed a patent for "concomitant administration of glucocorticoid receptor modulator relacorilant and paclitaxel, a dual substrate of cyp2c8 and cyp3a4" on Thu, August 8, 2024

Filed a patent for "methods of assessing selective glucocorticoid receptor modulation and of identifying and treating patients likely to benefit from glucocorticoid receptor modulation" on Fri, September 2, 2022

Filed a patent for "genetically engineered human pituitary corticotroph tumor organoids exhibit divergent responses to selective glucocorticoid receptor modulators" on Tue, September 6, 2022

Filed a patent for "pharmaceutical formulations containing relacorilant, a heteroaryl-ketone fused azadecalin compound" on Thu, February 2, 2023

Filed a patent for "formulations of glucocorticoid receptor modulators" on Thu, October 6, 2022

Filed a patent for "treatments for amyotrophic lateral sclerosis using dazucorilant" on Fri, October 28, 2022

Filed a patent for "treatment of hypercoagulopathy in cushing's syndrome by administration of glucocorticoid receptor modulators" on Thu, March 30, 2023

Filed a patent for "pyrimidine cyclohexenyl glucocorticoid receptor modulators" on Thu, June 15, 2023

Filed a patent for "treatments for amyotrophic lateral sclerosis using dazucorilant" on Tue, November 22, 2022

Filed a patent for "treatments for cushing's syndrome that do not significantly affect cardiac rhythms" on Wed, November 30, 2022

Filed a patent for "polymorphs of pyrimidine cyclohexyl glucocorticoid receptor modulators" on Thu, July 6, 2023

Filed a patent for "octahydro fused azadecalin glucocorticoid receptor modulators" on Thu, June 1, 2023

Filed a patent for "therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocorticoid receptor modulator" on Thu, April 27, 2023

Filed a patent for "piperazine indazole glucocorticoid receptor antagonists" on Thu, June 22, 2023